Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117095) titled 'The Potential Mechanisms of Efficacy Variability of Omalizumab in Chronic Spontaneous Urticaria and the Heterogeneity of IgE: Analysis of the BCR Immune Repertoire' on Jan. 20.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Chronic Spontaneous Urticaria
Intervention:
Non-disease-controlled study participants:None
Group of CSU patients unresponsive to antihistamines (CSU patients with total IgE >= 40 IU/mL who are unresponsive to antihistamines and receiving omalizumab):None
Recruitment Status: Recruiting
Phase: N/A
Date of Fi...